198 related articles for article (PubMed ID: 1657203)
61. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
62. Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.
Watkinson JC; Allen S; Lazarus CR; Laws D; Hibbert J; Clarke SE
Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):497-501. PubMed ID: 1963580
[TBL] [Abstract][Full Text] [Related]
63. A new imaging agent for medullary carcinoma of the thyroid.
Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
[TBL] [Abstract][Full Text] [Related]
64. False-positive uptake of Tc-99m penta-DMSA in fibrous dysplasia of breast in a patient with medullary carcinoma of thyroid.
Mudun A; Unal S; Ilhan R; Aktay R; Demiryont M; Cantez S
Clin Nucl Med; 1994 Apr; 19(4):364-5. PubMed ID: 7911752
[No Abstract] [Full Text] [Related]
65. 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.
Miyauchi A; Endo K; Ohta H; Torizuka K; Matsuzuka F; Kobayashi A; Kuma K; Maeda M
World J Surg; 1986 Aug; 10(4):640-5. PubMed ID: 3019022
[No Abstract] [Full Text] [Related]
66. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
Skowsky WR; Wilf LH
South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
[TBL] [Abstract][Full Text] [Related]
67. Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview): a preliminary report.
Nĕmec J; Nývltová O; Preiningerová M; Vlcek P; Racek P; Novák Z; Blazek T; Zimák J
Nucl Med Commun; 1995 Aug; 16(8):694-7. PubMed ID: 7491183
[TBL] [Abstract][Full Text] [Related]
68. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
[TBL] [Abstract][Full Text] [Related]
69. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
[TBL] [Abstract][Full Text] [Related]
70. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
Troncone L; Rufini V; De Rosa G; Testa A
Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
[TBL] [Abstract][Full Text] [Related]
71. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
[TBL] [Abstract][Full Text] [Related]
72. Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors.
Banci M; Bianchi PL; Gianni W; Romani AM; De Vincentis G; Ierardi M; Scopinaro F
Clin Nucl Med; 1996 Feb; 21(2):122-4. PubMed ID: 8697681
[TBL] [Abstract][Full Text] [Related]
73. A simplified kit for instant preparation of technetium-99m human immunoglobulin-G for imaging inflammatory foci.
Singh AK; Mishra P; Kashyap R; Chauhan UP
Nucl Med Biol; 1994 Feb; 21(2):277-81. PubMed ID: 9234294
[TBL] [Abstract][Full Text] [Related]
74. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid.
Blower PJ; Singh J; Clarke SE
J Nucl Med; 1991 May; 32(5):845-9. PubMed ID: 1850782
[TBL] [Abstract][Full Text] [Related]
75. Scintigraphic evaluation of tenosynovial giant-cell tumor using technetium-99m(V)-dimercaptosuccinic acid.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Konishi J; Kotoura Y; Yamamuro T; Endo K
J Nucl Med; 1993 Oct; 34(10):1745-7. PubMed ID: 8410292
[TBL] [Abstract][Full Text] [Related]
76. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.
Hirano T; Otake H; Yoshida I; Endo K
J Nucl Med; 1995 Feb; 36(2):202-7. PubMed ID: 7830114
[TBL] [Abstract][Full Text] [Related]
77. Distribution of renal parenchymal damage on 99m-Tc DMSA scintigraphy in vesico-ureteric reflux.
Kullendorff CM; Evander E
Ann Chir Gynaecol; 1990; 79(3):153-6. PubMed ID: 2176070
[TBL] [Abstract][Full Text] [Related]
78. Technetium-99m (V) DMSA uptake in amyloidosis.
Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
[TBL] [Abstract][Full Text] [Related]
79. Comparison of two 99mTc(V)-dimercaptosuccinic acid preparations.
Jeghers O; Puttemans N; Urbain D; Lefebvre J; Ham HR
Int J Rad Appl Instrum A; 1987; 38(1):13-8. PubMed ID: 3030963
[TBL] [Abstract][Full Text] [Related]
80. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
